Dr Anthony Byrne
- Honorary Clinical Senior Lecturer (Undergraduate Medical School)
email:
Anthony.Byrne@gla.systa-s.com
Department of Ageing & Health, Forth Valley Royal Hospital, Stirling Road, Larbert, FK5 4WR
Publications
2022
Quinn, T. J. et al. (2022) Research protocol – Assessing Post-Stroke Psychology Longitudinal Evaluation (APPLE) study: a prospective cohort study in stroke. Cerebral Circulation - Cognition and Behavior, 3, 100042. (doi: 10.1016/j.cccb.2022.100042) (PMID:36324404) (PMCID:PMC9616226)
2017
Maxwell, A. E. et al. (2017) Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study. Trials, 18(1), 162. (doi: 10.1186/s13063-017-1909-4) (PMID:28381307) (PMCID:PMC5382439)
2014
Henderson, D.J.P., Byrne, A., Dulla, K., Jenster, G., Hoffmann, R., Baillie, G.S. 
ORCID: https://orcid.org/0000-0003-2469-6316 and Houslay, M.D.
(2014)
The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.
British Journal of Cancer, 110(5),
pp. 1278-1287.
(doi: 10.1038/bjc.2014.22)
Articles
Quinn, T. J. et al. (2022) Research protocol – Assessing Post-Stroke Psychology Longitudinal Evaluation (APPLE) study: a prospective cohort study in stroke. Cerebral Circulation - Cognition and Behavior, 3, 100042. (doi: 10.1016/j.cccb.2022.100042) (PMID:36324404) (PMCID:PMC9616226)
Maxwell, A. E. et al. (2017) Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study. Trials, 18(1), 162. (doi: 10.1186/s13063-017-1909-4) (PMID:28381307) (PMCID:PMC5382439)
Henderson, D.J.P., Byrne, A., Dulla, K., Jenster, G., Hoffmann, R., Baillie, G.S. ORCID: https://orcid.org/0000-0003-2469-6316 and Houslay, M.D.
(2014)
The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.
British Journal of Cancer, 110(5),
pp. 1278-1287.
(doi: 10.1038/bjc.2014.22)